04:20pm European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading MT
09:58am UK-China business forum to be revived during expected PM Starmer trip AN
07:24am Britain, China to revive 'Golden Era' business dialogue during Starmer visit, sources say RE
07:20am Britain's AstraZeneca, BP, HSBC, IHG, JLR, Rolls Royce, Schroders, Stanchart expected to join - sources RE
07:20am Britain's Astrazeneca, BP, HSBC, IHG, JLR, Rolls Royce, Schroders, Stanchart expected to join - sources RE
01-20 European Stocks Close Lower in Tuesday Trading; UK Unemployment Rises to 5.1% MT
01-20 Global drugmakers rush to boost US presence as tariff threat looms RE
01-20 European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading MT
01-20 Sector Update: Health Care Stocks Decline Premarket Tuesday MT
01-20 Daiichi Sankyo - ENHERTU plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer AQ
01-20 Sector Update: Health Care MT
01-20 Stocks sink as Greenland tensions hit sentiment AN
01-20 London's FTSE 100 slips as Trump's tariff threats over Greenland loom RE
01-20 AstraZeneca to complete direct listing in NY on February 2 AN
01-20 AstraZeneca, Daiichi Sankyo Say European Medicines Agency Validates Enhertu Application for Breast Cancer MT
01-20 AstraZeneca to Delist ADSs, Debt Securities From Nasdaq MT
01-20 Euro-American Tensions Continue to Weigh on Stock Markets Zonebourse
01-20 Stockholm Bullets - Rottneros Plummets on a Red Exchange FW
01-20 AstraZeneca to Shift US Listing to New York Stock Exchange from Nasdaq MT
01-20 AstraZeneca to complete direct listing on NYSE RE
01-20 AstraZeneca to delist from Nasdaq, join NYSE in February RE
01-20 UK Stocks-Factors to watch on January 20 RE
01-19 Stockholm Stock Exchange Drops on Trump Tariff Threat, OMXS30 Index Falls 1.8 Percent FW
01-19 Daiichi Sankyo and AstraZeneca cheer EU milestone for cancer drug AN
01-19 European Medicines Agency Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer CI
No results for this search